CBP Launches New Process for IEEPA Duty Refunds – Effective April 20, 2026

2026-04-11T16:20:13+00:00April 10th, 2026|International Trade Issues, Risk Management, Trade Compliance, U.S. Customs, U.S. Tariffs, United States Imports|

CBP will launch the first phase of CAPE (within ACE) on April 20, 2026, to process IEEPA duty refunds. The platform comprises four modules — Claim Portal, Mass Processing, Review and Liquidation, and Refund and will be rolled out in phases, covering most entries while initially excluding select complex cases.

CBP Announces 2026 Quotas for Agricultural, Food, Preferential Goods & Other Products (Updated)

2026-04-08T05:06:49+00:00April 8th, 2026|International Trade Issues, Risk Management, Trade Compliance, U.S. Customs|

U.S. Customs and Border Protection announced 2026 tariff rate quotas for various products, including food, agricultural, brooms, apparel, and preferential goods. The quota period runs from January 1, 2026, to December 31, 2026, and quotas include specific limits and minimum access quantities for certain countries.

U.S. Adjusts Section 232 Tariffs on Aluminum, Steel and Copper – Full Customs Value Now Applies (Updated)

2026-04-09T21:36:40+00:00April 3rd, 2026|International Trade Issues, Trade Compliance, U.S. Customs|

Effective April 6, 2026, Section 232 tariffs on aluminum, steel, and copper now apply to the full customs value of imported products. The updated structure sets rates of 50% for metal articles, 25% for metal-heavy derivatives, and a transitional 15% through 2027 for industrial and electrical grid equipment. Products made entirely with US-origin metal qualify for 10%, while goods with 15% or less metal content are removed from scope. CBP guidance now available.

U.S. Imposes 100% Section 232 Tariffs on Patented Pharmaceuticals and Ingredients

2026-04-03T01:30:07+00:00April 3rd, 2026|International Trade Issues, Trade Compliance, U.S. Customs|

New U.S. Section 232 pharmaceutical tariffs introduce a 100% duty on patented drugs and APIs beginning in 2026, with tiered rates tied to onshoring and pricing agreements. While generics and specialty medicines remain exempt, companies can reduce tariffs to 0% through MFN pricing and domestic manufacturing commitments, signaling a major shift in global pharmaceutical supply chains and U.S. trade policy.

CIT Orders CBP to Process IEEPA Refunds; Order Expanded But Pause Continued

2026-03-22T14:01:51+00:00March 22nd, 2026|International Trade Issues, Trade Compliance, U.S. Customs|

On March 20, 2026, the U.S. Court of International Trade expanded its IEEPA refund order to include tariffs on Brazil and India but continued the pause on immediate enforcement. CBP is developing the ACE CAPE system to handle electronic submission, validation, and processing of IEEPA tariff refund claims for importers nationwide.

Register for CBP TRLED Webinars on Trade Violation Reporting (Mar 31 and April 2 Sessions Cancelled)

2026-03-22T14:11:34+00:00March 22nd, 2026|International Trade Issues, Trade Compliance, U.S. Customs|

The U.S. Customs and Border Protection (CBP) will host FY 2026 TRLED webinars on trade violation reporting. Sessions cover the Trade Violations Reporting tool and EAPA allegation filings. Due to a partial DHS shutdown, the March 31 and April 2 webinars are canceled. Registration is required for remaining sessions later this year.

USTR Launches Section 301 Investigations Into Forced Labor in 60 Economies

2026-03-17T18:16:19+00:00March 17th, 2026|International Trade Issues, Risk Management, Trade Compliance, U.S. Customs, U.S. Tariffs, United States Imports|

The United States Trade Representative has initiated Section 301 investigations into 60 economies over failure to enforce bans on goods produced with forced labor. The review will assess whether these practices burden U.S. commerce. Public comments are due April 15, 2026, with hearings scheduled for April 28 as consultations begin.

Go to Top